Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents
- PMID: 12531810
- DOI: 10.1182/blood-2002-08-2512
Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents
Abstract
2-Methoxyestradiol (2-ME), a new anticancer agent currently in clinical trials, has been demonstrated to inhibit superoxide dismutase (SOD) and to induce apoptosis in leukemia cells through a free radical-mediated mechanism. Because the accumulation of superoxide (O(2)-) by inhibition of SOD depends on the cellular generation of O(2)-, we hypothesized that the endogenous production of superoxide may be a critical factor that affects the antileukemia activity of 2-ME. In the present study, we investigated the relationship between cellular O(2)- contents and the cytotoxic activity of 2-ME in primary leukemia cells from 50 patients with chronic lymphocytic leukemia (CLL). Quantitation of O(2)- revealed that the basal cellular O(2)- contents are heterogeneous among patients with CLL. The O(2)- levels were significantly higher in CLL cells from patients with prior chemotherapy. CLL cells with higher basal O(2)- contents were more sensitive to 2-ME in vitro than those with lower O(2)- contents. There was a significant correlation between the 2-ME-induced O(2)- increase and the loss of cell viability. Importantly, addition of arsenic trioxide, a compound capable of causing reactive oxygen species (ROS) generation, significantly enhanced the activity of 2-ME, even in the CLL cells that were resistant to 2-ME alone. These results suggest that the cellular generation of O(2)- plays an important role in the cytotoxic action of 2-ME and that it is possible to use exogenous ROS-producing agents such as arsenic trioxide in combination with 2-ME to enhance the antileukemia activity and to overcome drug resistance. Such a combination strategy may have potential clinical applications.
Similar articles
-
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity.Cancer Chemother Pharmacol. 2004 Mar;53(3):209-19. doi: 10.1007/s00280-003-0726-5. Epub 2003 Nov 11. Cancer Chemother Pharmacol. 2004. PMID: 14610616
-
Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism.J Biol Chem. 2003 Sep 26;278(39):37832-9. doi: 10.1074/jbc.M301546200. Epub 2003 Jul 9. J Biol Chem. 2003. PMID: 12853461
-
Acquisition of resistance of pancreatic cancer cells to 2-methoxyestradiol is associated with the upregulation of manganese superoxide dismutase.Mol Cancer Res. 2012 Jun;10(6):768-77. doi: 10.1158/1541-7786.MCR-11-0378. Epub 2012 Apr 30. Mol Cancer Res. 2012. PMID: 22547077 Free PMC article.
-
Cytotoxic effects of B lymphocytes mediated by reactive oxygen species.Curr Pharm Des. 2004;10(8):841-53. doi: 10.2174/1381612043452848. Curr Pharm Des. 2004. PMID: 15040354 Review.
-
Synthetic 2-methoxyestradiol derivatives: structure-activity relationships.Curr Med Chem. 2012;19(24):4142-56. doi: 10.2174/092986712802430072. Curr Med Chem. 2012. PMID: 22709003 Review.
Cited by
-
Fluorescence imaging sheds light on the immune evasion mechanisms of hepatic stellate cells mediated by superoxide anion.Commun Biol. 2024 May 10;7(1):558. doi: 10.1038/s42003-024-06245-y. Commun Biol. 2024. PMID: 38730013 Free PMC article.
-
Potential New Therapies "ROS-Based" in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis.Antioxidants (Basel). 2024 Apr 17;13(4):475. doi: 10.3390/antiox13040475. Antioxidants (Basel). 2024. PMID: 38671922 Free PMC article. Review.
-
Comprehensive analysis of CYBB as a prognostic marker and therapeutic target in glioma: A bioinformatics approach.Heliyon. 2024 Apr 14;10(8):e29549. doi: 10.1016/j.heliyon.2024.e29549. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38655339 Free PMC article.
-
New Derivatives of 1-(3-Methyl-1-Benzofuran-2-yl)Ethan-1-one: Synthesis and Preliminary Studies of Biological Activity.Int J Mol Sci. 2024 Feb 7;25(4):1999. doi: 10.3390/ijms25041999. Int J Mol Sci. 2024. PMID: 38396676 Free PMC article.
-
The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia.Cancers (Basel). 2023 Oct 26;15(21):5160. doi: 10.3390/cancers15215160. Cancers (Basel). 2023. PMID: 37958334 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical